Welcome to LookChem.com Sign In|Join Free
  • or
N-(6-chloro-pyridin-3-yl)-formamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

206006-29-3

Post Buying Request

206006-29-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

206006-29-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 206006-29-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,0,0 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 206006-29:
(8*2)+(7*0)+(6*6)+(5*0)+(4*0)+(3*6)+(2*2)+(1*9)=83
83 % 10 = 3
So 206006-29-3 is a valid CAS Registry Number.

206006-29-3Relevant academic research and scientific papers

Method for preparing netupitant

-

Paragraph 0047-0049, (2018/04/02)

The invention discloses a method for preparing netupitant, and belongs to the field of medicine compounds. The method includes the steps: performing condensation on 2-chloro-5-aminopyridine and formicacid; performing reduction, Boc protection and iodination; performing coupling and deprotection and then performing condensation on products and 2-(3, 5-bis-trifluoromethyl-phenyl)-2-methyl propionicacid; performing substitution on products and N-methylpiperazine to obtain the netupitant. The method has the advantages that the steps of processes for preparing the netupitant have fewer side effects, the method is high in yield and less in environmental pollution, after-treatment is simple, and the netupitant which is a product prepared by the aid of the method is high in purity and low in individual impurity content.

PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS

-

Page/Page column 25, (2008/12/04)

This invention relates to novel purinyl derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 206006-29-3